Learn More
Medchemexpress LLC GSK2879552 dihydrochloride | 1902123-72-1 | 99.8% | 437.40 | 100 MG

Supplier: Medchemexpress LLC HY18632A100MG
GSK2879552 dihydrochloride is an orally active, selective, and irreversible inhibitor of lysine specific demethylase 1 (LSD1/KDM1A), which has potential antineoplastic activity. For research use only, it is not sold to patients.
- Orally active.
- Selective and irreversible inhibitor of LSD1/KDM1A.
- Exhibits potential antineoplastic activity.
- Inhibits KDM1A histone demethylase activity, inducing differentiation of sorafenib-resistant cells and attenuating stemness properties in vitro.
- Depresses the transcription of Wnt antagonists and downregulates β-catenin signaling activity in sorafenib-resistant cells in vitro.
- In vivo treatment with 1.5 mg/kg exhibits tumor growth inhibition in SCLC xenograft bearing mice.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.